PENNINGTON BIOMEDICAL RESEARCH CENTER
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1988-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.pbrc.edu
Clinical Trials
272
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (180 trials with phase data)• Click on a phase to view related trials
GLP-1R Actions on Muscle and the Skeleton
- Conditions
- Musculoskeletal AbnormalitiesObesitySarcopenic ObesityOsteoporosisDrug Effect
- Interventions
- Behavioral: Lifestyle toolkit
- First Posted Date
- 2025-09-04
- Last Posted Date
- 2025-09-04
- Lead Sponsor
- Pennington Biomedical Research Center
- Target Recruit Count
- 50
- Registration Number
- NCT07154719
- Locations
- 🇺🇸
Robert L. Dubin, MD, Baton Rouge, Louisiana, United States
Dietary Iron Requirements
- Conditions
- Iron Absorption
- First Posted Date
- 2025-08-24
- Last Posted Date
- 2025-08-24
- Lead Sponsor
- Pennington Biomedical Research Center
- Target Recruit Count
- 300
- Registration Number
- NCT07139821
- Locations
- 🇺🇸
LSU Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
🇺🇸Cornell University, Ithaca, New York, United States
Continuous Glucose Monitoring in Metabolic Surgery
- Conditions
- DiabetesObesity (Disorder)
- First Posted Date
- 2025-07-31
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Pennington Biomedical Research Center
- Target Recruit Count
- 20
- Registration Number
- NCT07095972
- Locations
- 🇺🇸
Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants
- Conditions
- Infant Body Composition and MetabolismMetabolismEnergy ExpenditureInfant FormulaHuman Milk, Breast MilkMetabolic Flexibility
- First Posted Date
- 2025-07-31
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- Pennington Biomedical Research Center
- Target Recruit Count
- 40
- Registration Number
- NCT07096011
- Locations
- 🇺🇸
Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
Multicomponent Program for Addressing Cognition in Rural Communities
- Conditions
- Cognitive Decline
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Pennington Biomedical Research Center
- Target Recruit Count
- 11
- Registration Number
- NCT07018830
- Locations
- 🇺🇸
Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 55
- Next
News
Synthetic Peptide Pep19 Shows Promise in Reducing Visceral Fat and Improving Sleep in Obese Adults
A triple-blind clinical trial involving 24 obese adults demonstrated that Pep19, a synthetic peptide, achieved a 17% reduction in visceral fat over 60 days without affecting lean body mass.
Answer ALS Launches AI-Powered Drug Discovery Initiative to Accelerate ALS Treatment Development
Answer ALS has launched LADDIA, a groundbreaking AI-powered drug discovery collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane University to accelerate ALS treatment development.
Physical Activity Significantly Improves Survival Outcomes in Stage III Colon Cancer Patients
New research reveals that stage III colon cancer patients who engage in high levels of physical activity (≥18.0 MET-hours/week) show survival rates comparable to the general population.